SeqWright Expands Next Generation Lineup with the Addition of 454's GS FLX(TM) System

HOUSTON, April 14 /PRNewswire/ -- SeqWright Inc., a leading Genomics CRO, has added 454's GS FLX(TM) system to increase the breadth of its next generation offerings and to provide genomic researchers with more cost effective genomics solutions. The GS FLX(TM) system will complement SeqWright's current ABI SOLiD(TM) platform and enable the company to offer a more diverse array of next generation services, including de novo sequencing of higher organisms. This dual-system model is designed to make genomics projects of any size and scope accessible to vastly more researchers and thereby, increase the pace of genomics research.

The addition of the GS FLX(TM) system brings with it a ten fold increase in sequence read-length compared to other next generation platforms; reads which approach those of Sanger-based technologies. The increased read length of the GS FLX(TM) system is the primary factor behind SeqWright's capability of offering de novo sequencing of higher organisms and the system's greatest advantage over competitive platforms.

The capacity of SeqWright to provide cost effective genomic solutions for virtually any genomics project stems from the synergy created by the combination of the GS FLX(TM) with the company's existing SOLiD(TM) platform. The long read lengths of the GS FLX(TM) combined with the extremely high throughput of SOLiD(TM) are a perfect complement to each other. For example, utilizing the strengths of the two systems, SeqWright can create a scaffold sequence using the long reads of the GS FLX(TM) and subsequently combine that scaffold with the vast amounts of sequence data from SOLiD(TM) to build up the genomic coverage. When compared to Sanger-based methods, the decrease in cost and the increase in speed of SeqWright's dual-system, next generation, approach is remarkable.

SeqWright Senior VP, David Buck, Ph.D., remarked this regarding SeqWright's recent acquisition, "The 454 platform is quite a natural addition to our next generation services division as it enables us to take on many more large-scale genomics projects and makes these sort of projects within reach of many more genomics researchers."

About SeqWright:

SeqWright Incorporated is a world-class genomic services support organization based in Houston, TX with more than fourteen years of experience specializing in providing access to state of the art Molecular Biology and Genomic services in a highly regulated GLP/CLIA environment. For additional information about SeqWright and its services, please visit http://www.seqwright.com.

SOURCE SeqWright Incorporated

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.